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Radical cystectomy with ileal conduit diversion remains the standard treatment for invasive
bladder cancer. We report a patient with urothelial carcinoma of the urinary bladder and found
metastasis to the orbit post radical cystectomy and ileal conduit diversion presenting as blurred
vision and diagnosed by open biopsy. The orbit is an infrequent site of metastasis from bladder
cancer cells. To the best of our knowledge, there are fewer than 10 case reports of orbital metastasis
from urothelial carcinoma reported in the English medical literature.
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Several types of tumors can lead to orbital involve-
ment. Metastatic disease to the orbit is relatively
uncommon, with the incidence ranging from 1% 
to 13% among the reported series of orbital tumors
[1–3].
Breast carcinoma is the most common primary
source of orbital metastasis [1,4]. Other tumors in 
the order of frequency are lung cancer, alimentary
tract malignancies, and less common cancers of the
thyroid, prostate, kidney, testicles, pancreas, ovary,
and liver.
There are fewer than 10 case reports of urothe-
lial tumors of the urinary bladder with orbital or
choroidal metastases. Here, we provide a new case of
urothelial carcinoma of the urinary bladder with
metastasis to the orbit.
CASE PRESENTATION
A 60-year-old man presented with blurred vision 
in the right eye and progressive diplopia 8 months 
following radical cystectomy with ileal conduit
diversion and three courses of chemotherapy (CT)
(MVAC) for bladder cancer (pT3aN1Mo). Clinical
examination of his eye found axial proptosis with
chemosis of the conjunctiva. No light perception 
in his right eye was noted and the fundus exam-
ination showed disc edema. Extraocular move-
ments were restricted in all directions, in particular
elevation.
Hemogram and biochemical investigations were
within normal limits. Contrast-enhanced computed
tomography of the orbit showed an ill-demarcated
soft tissue lesion at the upper medial aspect of 
the right orbit, involving retrobulbar spaces (Figure
1). The patient underwent a biopsy of the right
orbital mass. Histologic findings showed irregular
islands of transitional carcinoma, which were strongly
positive for cytokeratin 7 and 20 (Figure 2). The 
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Figure 1. (A) Axial computed tomography demonstrates an orbital mass (star) causing unilateral exophthalmos. (B) Coronal view
shows intact adjacent bony structures.
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Figure 2. (A) Infiltrating hyperchromatic cancer cells with high N/C ratio in desmoplastic fibrous stroma (hematoxylin & eosin,
100 ×). Immunohistochemical stains reveal that the tumor cells are immunoreactive for (B) cytokeratin 7 and (C) cytokeratin 20, and
negative for (D) vimentin.
sections were consistent with metastatic transitional
carcinoma.
In view of a clinical course suggestive of metastatic
transitional cell carcinoma (TCC), the fourth palliative
systemic CT (MVAC) was started. No further metasta-
tic site was detected on imaging surveys after 6 months.
But there was no improvement in his vision during
follow-up.
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DISCUSSION
Orbital metastases are uncommon, accounting for
between 2.5% and 8.1% of all orbital space-occupying
lesions [5]. The majority are adenocarcinoma and the
most common primary site is the breast. Prostate,
colon, and lung cancers can also metastasize to the
orbit. TCC is a common bladder tumor, 10–15% of
which will exhibit invasive behavior. About 50% of
patients with invasive TCC will eventually develop
distant metastases [6]. Lymph nodes, lungs, and
bones are often involved.
Urinary tract carcinoma is an extremely rare source
of ocular metastases. Souza Filho et al [7] reported the
latest case of ocular metastases from carcinoma urinary
bladder in 2005; seven cases of orbital metastasis from
TCC of the bladder have previously been reported
(Table). These included six men and two women,
with a mean age of 64 years (range, 43–79 years). All
cases presented with orbital metastases within 3 years
of diagnosis of the primary tumors, which were all
locally invasive. Most patients died within 6 months
of developing metastatic disease.
From previous reports, we know that the natural
history of these rare lesions is of rapid progression with
early loss of vision and proptosis. A detailed metastatic
work-up should be carried out to detect occult primar-
ies at other sites. Fifteen percent of these lesions have
been associated with lung involvement [8]. In our case,
the palliation of this aggressive metastatic complica-
tion is obtained with multiagent CT (MVAC) without
obvious adverse effect. Local radiotherapy may be
combined with systemic CT from the experience of
Resnick et al [8] but refused by the patient himself.
Presenting symptoms vary due to the affected site
in the ocular region. When the tumor infiltrates the
choroids, blurred vision is the predominant result,
whereas glaucoma might occur in cases with mani-
festations in the anterior eye. Exophthalmus and bulb
divergence occur when large tumors are present [9].
In our case, the 60-year-old man had an interval of
8 months between diagnosis of the primary bladder
tumor and the development of orbital metastasis. It
highlights the possibility of metastasis to the ocular
region in patients with urothelial carcinoma and the
need for a high index of suspicion by the treating
physician whenever a patient with urothelial carcinoma
presents with nonspecific eye symptoms. A prompt
ophthalmologic and radiologic evaluation is required
to diagnose and treat these lesions correctly.
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